Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Zurich
With
University Children's Hospital, Zurich
Ehlers-Danlos Network, Switzerland
Ehlers-Danlos Syndrome (EDS) is a clinically and genetically heterogeneous group of inherited connective tissue disorders characterized by joint hypermobility, skin hyperextensibility, and tissue fragility. EDS features such as genetically related cartilage defects, craniofacial abnormalities and increased pharyngeal collapsibility have been proposed to cause obstructive sleep apnoea (OSA). There is evidence from studies based on questionnaires that EDS patients might be more frequently affected by OSA and sleep disturbances than the general population. However, the actual prevalence of OSA in children and adolescents with EDS is unknown.
The primary objective of this study is to assess the prevalence of OSA in children and adolescents with EDS compared to a matched control group. The secondary objective of this pioneer study is to assess the quality of life in children and adolescents in EDS in comparison to healthy children and adolescents.
Age
0–18
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Informed consent
Diagnosis of Ehlers-Danlos Syndrome (not for control group)
You may not be if
Moribund or severe disease prohibiting protocol adherence
Continuous positive airway pressure treatment for OSA during sleep study
Physical or intellectual impairment precluding informed consent or protocol adherence